G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
Xiaoxin X. Wang(Georgetown University), Moshe Levi(Georgetown University), Jeffrey B. Kopp(Kidney Care UK), Jonathan Levi(National Institutes of Health), Yuhuan Luo(University of Colorado Anschutz Medical Campus), Moin A. Saleem(At Bristol), Evgenia Dobrinskikh(Inserm), Luciano Adorini(Intercept Pharmaceuticals (United States)), Uzi Gafter(Rabin Medical Center), Michal Herman Edelstein(Tel Aviv University), Scott Lucia(University of Colorado Anschutz Medical Campus), Liru Qiu(University of Colorado Anschutz Medical Campus), Avi Z. Rosenberg, Vivette D. D’Agati(Columbia University), David Gius(The University of Texas at San Antonio Health Science Center)
Cited by 208
Related Papers
Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial
|The Lancet|2000|1k
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
|Journal of Lipid Research|2013|627